Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
99.115,00
0,44%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ EXACT Sciences Corporation (EXAS) EXACT Sciences Corporation (EXAS) Notizie

EXACT Sciences Corporation

EXAS
58,11
-0,82 (-1,39%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202422:30EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
26/11/202412:00BWExact Sciences to Participate in December Investor..
25/11/202423:35BWExact Sciences Advances Breast Cancer Care with the Oncotype..
13/11/202420:58EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202419:00BWExact Sciences Unveils Data Showing Promise of Multi-Cancer..
13/11/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202412:09IHMARKETNEWSTrump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%;..
05/11/202423:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202422:09EDGAR2Form 8-K - Current report
05/11/202422:05BWExact Sciences Announces Third-Quarter 2024 Results
05/11/202412:46IHMARKETNEWSU.S. Index Futures Rise as Election Looms; Oil and Gold..
01/11/202411:00BWExact Sciences to Participate in November Investor..
27/10/202417:00BWExact Sciences Presents Multiple Studies at ACG 2024..
09/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202419:27EDGAR2Form 144 - Report of proposed sale of securities
08/10/202412:00BWExact Sciences Schedules Third Quarter 2024 Earnings Call
04/10/202422:00EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/10/202412:00BWFDA Approves Exact Sciences’ Cologuard Plus Test, Setting a..
19/9/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:15EDGAR2Form 144 - Report of proposed sale of securities
16/9/202408:35BWExact Sciences Presents Data Demonstrating Advancement in..
28/8/202412:00BWExact Sciences to Participate in September Investor..
20/8/202413:00BWExact Sciences Announces First Patient Enrolled in its..
15/8/202413:00BWNew Modeling Data Show the Cologuard® Test Has Detected More..
06/8/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202423:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202422:08EDGAR2Form 8-K - Current report
31/7/202422:05BWExact Sciences Announces Second-Quarter 2024 Results
08/7/202412:00BWExact Sciences schedules second quarter 2024 earnings call
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/6/202413:00EDGAR2Form 8-K - Current report
03/6/202413:01EDGAR2Form 8-K - Current report
28/5/202412:00BWExact Sciences to Participate in June Investor Conferences
25/5/202413:32BWASCO®: Exact Sciences bekräftigt mit mehreren..
24/5/202418:46BWExact Sciences démontre son leadership continu en matière de..
24/5/202412:05BWExact Sciences Demonstrates Continued Leadership in Early..
22/5/202413:30BWExact Sciences Earns 2024 Great Place To Work®..
21/5/202412:05BWCourt Ruling Enables Exact Sciences to Proceed with Lawsuit..
08/5/202423:10EDGAR2Form 8-K - Current report
08/5/202423:08EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
08/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 58,21 Min: 57,64 Max: 58,95
Chiusura: 58,93

La tua Cronologia

NASDAQ
EXAS
EXACT Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network